ARCHIVES

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Tobacco Council Awards New Grants

April 18, 1980

NTP Panel Completed To Write New Testing, Evolution Guidelines

April 22, 1983

Monitoring of Clinical Trials Finds Two Major Problems; Investigators Are Suspended

August 19, 1983

Calif. Stem Cell Group To Collaborate With Canadians.

June 20, 2008

NCAB Supports ACS Effort To Work With Centers

March 1, 1991

Zubrod To Retire as Miami Director; Baker Succeeds Brennan As Director Of Detroit Center

January 29, 1988